ESTA — Establishment Labs Holdings Inc. stock price, charts and financials

QT73Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
76.72
-0.70-0.91%
OverviewShort InterestFilings
ESTAQT73Establishment Labs Holdings Inc.·NASDAQ
76.72-0.91%
TA
Loading chart...
Signal & projected range
Earnings big miss — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
BFLY+11.66%$9.86UFPT+1.59%$318.99AXGN+1.97%$47.34NVCR+5.96%$17.37TMDX+3.17%$86.55INSP+0.79%$60.63TNDM+0.09%$22.40ENOV-6.18%$24.96
Snapshot
Index-P/E-EPS (ttm)-1.48Insider Own-Shs Outstand29.43MPerf Week-16.34%
Market Cap2.28BForward P/E-EPS next Y0.02Insider Trans-2.11%Shs Float26.95MPerf Month-12.79%
Enterprise Value2.21BPEG-EPS next Q-Inst Own-Short Float16.64%Perf Quarter7.48%
Income-38.05MP/S9.27EPS this Y22.52%Inst Trans-Short Ratio7.35Perf Half Y16.67%
Sales245.82MP/B107.93EPS next Y101.41%ROA-11.05%Short Interest4.48MPerf YTD6.23%
Book/sh-P/C-EPS next 5Y-ROE-203.88%52W High96.70 -20.67%Perf Year85.26%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-5.35%52W Low33.05 132.14%Perf 3Y15.05%
Dividend Est.-EV/EBITDA-Sales past 3/5Y9.21% 19.94%Gross Margin70.49%Volatility7.28% 4.67%Perf 5Y-2.36%
Dividend TTM-EV/Sales8.99EPS Y/Y TTM50.67%Oper. Margin-7.63%ATR (14)4.71Perf 10Y-
Dividend Ex-Date-Quick Ratio2.52Sales Y/Y TTM38.55%Profit Margin-15.82%RSI (14)30.24Recom2.14
Dividend Gr. 3/5Y-Current Ratio3.84EPS Q/Q42.86%SMA20-14.61%Beta1.04Target Price102.00
Payout0.00%Debt/Eq0.09Sales Q/Q46.34%SMA50-9.79%Rel Volume1.25Prev Close77.42
Employees1,004LT Debt/Eq10.46EarningsNov 04SMA2008.08%Avg Volume601.64KPrice76.72
IPO DateJul 19, 2018Option/ShortYes / YesEPS/Sales Surpr.-12.69% 4.32%Net Debt/EBITDA10.34Volume754,113Change-0.91%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedBTIGBuy$96 → $103
Aug-06-26ReiteratedNeedhamBuy$84 → $95
Aug-06-26ReiteratedCanaccord GenuityBuy$85 → $105
Jul-15-26ReiteratedMizuhoOutperform$70 → $105
Dec-31-25ReiteratedBTIGBuy$81 → $86
Dec-17-25ReiteratedCanaccord GenuityBuy$85
Dec-10-25ReiteratedNeedhamBuy$70 → $84
Nov-14-25ReiteratedBTIGBuy$70 → $81
Nov-06-25ReiteratedNeedhamBuy$70
Nov-05-25ReiteratedBTIGBuy$110 → $70
Latest News
Aug-07-26
Aug-07-2611:53AM
JP Morgan Maintains Overweight on Establishment Labs Hldgs, Raises Price Target to $95Benzinga
Aug-06-26
Aug-06-2606:24PM
Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcriptseekingalpha.com
01:05PM
Establishment Labs Q2 Earnings Call Highlightsmarketbeat.com
10:51AM
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimateszacks.com
08:00AM
Establishment Labs® Reports Second Quarter 2026 Financial Resultsbusinesswire.com
Jul-31-26
Jul-31-2608:35AM
Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial StockBenzinga
Jul-23-26
Jul-23-2608:00AM
Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6businesswire.com
Jul-21-26
Jul-21-2603:14AM
AlTi Global Inc. Makes New Investment in Establishment Labs Holdings Inc. $ESTAdefenseworld.net
Jul-15-26
Jul-15-2602:26PM
Mizuho Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $105Benzinga
Jul-08-26
Jul-08-2611:32AM
Citigroup Maintains Neutral on Establishment Labs Hldgs, Raises Price Target to $92Benzinga
Jul-07-26
Jul-07-2611:30AM
Establishment Labs Holdings (NASDAQ:ESTA) Meets Minervini Trend Template and High Growth Momentum CriteriaChartMill
Jul-05-26
Jul-05-2605:18PM
A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.fool.com
Jun-29-26
Jun-29-2608:00AM
Establishment Labs® Appoints Taylor Harris to Board of Directorsbusinesswire.com
Jun-25-26
Jun-25-2608:05AM
Establishment Labs Set To Join Russell 2000 Index, Effective June 29Benzinga
Company

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue247211166——————
Cost of Goods Sold Incl. D&A736557——————
Gross Profit174146110——————
Selling, General and Administrative Excl. Other125165140——————
Research and Development202020——————
Other Operating Expense
4700——————
Operating Income-19-39-50——————
Interest Expense272521——————
Unusual Expense
—————————
Non-Operating Income (Expense)06-14——————
Net Income Before Taxes-48-58-85——————
Income Taxes-9-70——————
Consolidated Net Income-39-51-85——————
Net Income From Continuing Operations-39-51-85——————
Net Income-39-51-85——————
EPS (Recurring)-1.31-1.72-3.00——————
EPS (Basic, Before Extraordinaries)-1.31-1.72-3.00——————
EPS (Diluted)-1.31-1.72-3.00——————
EBITDA-6-22-56——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio9.3210.367.77——————
Gross Margin70.4569.1966.27——————
Operating Margin-7.69-18.48-30.12——————
Net Margin-15.79-24.17-51.20——————
Shares Outstanding303028——————
Market Capitalization2,3012,1861,290——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$104.95$84.79$64.64$44.48$24.32● Close Price0.00M6.47M12.93M19.40M25.87MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
JW Asset Management, LLCother: See footnote 3May 28 '26Sale72.8965,1004,745,1392,890,582May 28
JW Asset Management, LLCother: See footnote 3May 27 '26Sale72.501138,1932,955,682May 28
JW Asset Management, LLCother: See footnote 3May 26 '26Sale74.3925,3201,883,5552,955,795May 28
JW Asset Management, LLC10% OwnerMay 21 '26Sale71.4016,9991,213,7292,981,115May 22
JW Asset Management, LLC10% OwnerMay 20 '26Sale70.563,580252,6052,998,114May 22
JW Asset Management, LLC10% OwnerMay 06 '26Sale75.6360,0004,537,5003,001,694May 08
Chacon Quiros Juan JoseDirectorMay 06 '26Sale75.42105,0007,918,872927,504May 08
Chacon Quiros Juan JoseDirectorMay 04 '26Sale70.487,751546,3081,032,504May 04
Chacon Quiros Juan JoseDirectorMay 01 '26Sale70.7867,2494,759,5691,040,255May 04
Chacon Quiros Juan JoseDirectorApr 27 '26Sale66.262,180144,4391,107,504Apr 27
Chacon Quiros Juan JoseDirectorApr 24 '26Sale65.7830,1781,984,9691,109,684Apr 27
Chacon Quiros Juan JoseDirectorApr 23 '26Sale65.4342,6422,790,0701,139,862Apr 27
Chacon Quiros Juan JoseDirectorApr 14 '26Sale65.2337,5002,446,0501,182,504Apr 16
SCHUTTER EDWARD JDirectorApr 02 '26Option Exercise4.1136,780151,166175,382Apr 02
Chacon Quiros Juan JoseDirectorMar 25 '26Sale60.083,575214,7681,220,004Mar 27
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.